Yukun Li
Zhuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Research progress on metabolic abnormalities in myocardial hypertrophy.
Journal: Frontiers in cardiovascular medicine
Published: June 18, 2026
Neoantigen-based TCR-T therapy in solid tumors.
Journal: International review of cell and molecular biology
Published: May 26, 2026
Lipid metabolic reprogramming of CD8+ T cells in the tumor microenvironment.
Journal: Cellular signalling
Published: January 23, 2026
ENO1 lactylation drives bevacizumab resistance through metabolic reprogramming and angiogenesis in ovarian cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: January 03, 2026
ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis.
Journal: Neoplasia (New York, N.Y.)
Published: November 18, 2025
Integrating multi-omics and machine learning systematically deciphers cellular heterogeneity and fibrotic regulatory networks in the progression from MASLD to MASH.
Journal: NPJ digital medicine
Published: November 10, 2025
Mechanisms and Opportunities of the Arrestin Beta Signaling Pathway in Liver Diseases.
Journal: DNA and cell biology
Published: October 22, 2025
ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value.
Journal: Diagnostic pathology
Published: October 01, 2025
Machine learning-enabled spatial multi-omics uncovers lactate-driven targets and tumor microenvironmental reprogramming in cancer.
Journal: NPJ digital medicine
Published: August 09, 2025
Lactic Acid Drives ESM1 to Attenuate DNA Damage and CD8+ T Cell Infiltration in Cancer.
Journal: Oncology research
Published: August 06, 2025
Last Updated: 09/26/2026